A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma

Jenny Lam, Joel W. Hay, Jonathan Salcedo, Nicholas Kenyon

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint Dive into the research topics of 'A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma'. Together they form a unique fingerprint.

Medicine & Life Sciences